The Real Life Topical Field Treatment of Actinic Keratosis Study
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This non-interventional, multinational study of topical field treatment of actinic keratosis
(AK) aims to collect real-life experience with ingenol mebutate as well as one or two other
topical field therapies commonly used in the individual country. Physicians will report
baseline characteristics, while the main study focus will be on patient reported outcomes 3-4
weeks after treatment completion (treatment satisfaction, adherence, resource utilization and
Health Related Quality of Life.
Dermatology centres in Denmark, Norway, Sweden, the Netherlands, the United Kingdom and
Canada will participate.